-
Loading metrics
The FLT3 Inhibitor Quizartinib Inhibits ABCG2 at Pharmacologically Relevant Concentrations, with Implications for Both Chemosensitization and Adverse Drug Interactions
- Jasjeet Bhullar,
- Karthika Natarajan,
- Suneet Shukla,
- Trevor J. Mathias,
- Mariola Sadowska,
- Suresh V. Ambudkar,
- Maria R. Baer
x
- Published: August 14, 2013
- https://doi.org/10.1371/journal.pone.0071266